Skip To Navigation Skip To Content Skip To Footer
    Insight Article
    Home > Articles > Article
    MGMA Insights
    MGMA Revenue Cycle Insights

    Editor’s note: This article builds on themes first explored in Navigating Insurance Participation for Private Practices: Mitigating Risk and Maximizing Reward, an ACMPE Fellowship paper by Angela Patterson, FACMPE, CPCO (July 2020).

    Half of medical group leaders said their practice's most recent commercial payer rate increase came three or more years ago. Another 29% reported an increase within the past year.¹ By leaders' accounts, collecting on existing rates also takes more work. In a September 2026 poll, 44% said payers' prior-authorization decisions were slower than in 2025, and 7% said they were faster.² In comments on a July poll, leaders described downcoded claims that had to be appealed before the practice could collect the full amount, along with record requests and prepayment audits that delayed payment.³

    Some groups have responded by leaving networks. In March 2024, Community Care Physicians, a multispecialty group with more than 420 clinicians in 70 practices in New York's Capital Region, went out of network with Humana's Medicare Advantage plans. In a letter to patients, the group said Humana's requirements had become "increasingly cumbersome."⁴ By mid-November 2026, Becker's Hospital Review listed 40 health systems dropping Medicare Advantage plans.⁵

    Leaving is one of several responses. A participation review, done each year for every payer product, shows what each product pays after friction, which contract terms drive that result and which response fits.

    What changed in the payer market

    Several changes since the late 2010s affect how a participation decision should be made.

    • Medicare Advantage is most of Medicare. In 2026, 35.2 million people, 55% of eligible Medicare beneficiaries, were enrolled in Medicare Advantage (MA) plans, according to KFF.⁶ For many practices, the Medicare share of the payer mix is now a set of private contracts, each with its own network, prior-authorization and appeal rules. For 2027, UnitedHealth Group is ending general-enrollment MA drug plans in 228 counties, CVS Health in 186 and Humana in 62, KFF found, so confirm which products remain locally.⁷ Among six large MA insurers, an average of 12% of standard prior-authorization requests were denied in 2025, ranging from 5% to 17% by insurer, and 67% of appealed denials were overturned, KFF found.⁸ That overturn rate describes the denials someone chose to appeal, which may differ from the rest.
    • Payer policies can lower what a contract pays. Several large payers now review level 4 and 5 evaluation and management (E/M) claims and downcode those they judge the documentation does not support. Cigna's policy took effect Oct. 1, 2025, for codes 99204–99205, 99214–99215 and 99244–99245. Aetna, Anthem Blue Cross of California and Blue Cross Blue Shield of Massachusetts have announced reviews of their own.⁹ In 2026, Maryland regulators ordered Cigna to stop the practice there, and Indiana and Illinois passed laws limiting downcoding.¹⁰
    • Percentage-of-Medicare contracts move with Medicare. A contract that pays a percentage of the current year's Medicare Physician Fee Schedule passes Medicare's conversion-factor changes through to the commercial rate. The 2027 final rule, released Nov. 4, cuts the conversion factor 2.31% for most clinicians, to $32.63, and 1.83% for qualifying alternative payment model participants.¹¹ It also cuts payment 20% for the lower-paid service when a modifier 25 office visit shares a day with a 0-day global procedure. MGMA has urged Congress to address both.¹²
    • Negotiated rates are public. Since July 2022, most group health plans and insurers have posted machine-readable files of in-network rates under the federal Transparency in Coverage rules. Final rules issued in October 2026 move the files to quarterly updates beginning April 1, 2027, organize them by provider network and add product type and network identifiers.¹³ In a December 2025 MGMA poll, less than one in five (18%) say their group used the data in payer negotiations.¹⁴
    • Coverage is less stable. After enhanced ACA premium tax credits expired at the end of 2025, the number of marketplace enrollees who had paid their premiums fell from 22.1 million in 2025 to 19.2 million in February 2026, according to KFF's analysis of federal data.¹⁵ Bronze plans, which carry higher deductibles, rose to 40% of 2026 plan selections.¹⁶ For 2027, benchmark premiums are up 13% on average and 11 carriers, including Cigna, are leaving at least one state.¹⁷ In Medicaid, adults in the expansion group face renewals every six months, beginning with renewals scheduled on or after Jan. 1, 2027, and community engagement (work requirement) checks at those renewals.¹⁸ A Nov. 13, 2026, CMS letter lets states delay coverage losses tied to those checks through June 30, 2027.¹⁹ The membership behind a contract, and the share of each bill that patients owe, can shift within a contract year.

    Start with products, not payer names

    One carrier can appear in the payer mix as several contracts with different rules: a fully insured commercial plan regulated by the state, a self-funded employer plan the carrier administers, an ACA marketplace plan, MA HMO and PPO plans, a special needs plan for people eligible for both Medicare and Medicaid, and a Medicaid managed care plan.

    Sign in to access this material

    Sign In Become a Member
    MGMA Insights

    Written By

    MGMA Revenue Cycle Insights

    MGMA Revenue Cycle Insights is developed by MGMA’s in-house team of editors and subject-matter experts who understand the full lifecycle of getting paid — from patient access and insurance verification to coding, claims submission, denial management, and collections. This work is grounded in how revenue actually moves through a practice. MGMA draws on member insights and benchmarking data to address front-end accuracy, charge capture, first-pass denial rates, payer behavior, and patient payment trends. The content focuses on reducing friction across the revenue cycle — improving clean claim rates, shortening days in A/R, and strengthening financial performance. Whether addressing prior authorization workflows, documentation gaps, payer underpayment, or patient responsibility collection, MGMA’s guidance is built for leaders responsible for ensuring the practice gets paid accurately and on time.


    Explore Related Content

    More Insight Articles

    An error has occurred. The page may no longer respond until reloaded. An unhandled exception has occurred. See browser dev tools for details. Reload 🗙